REMICADE (R) Receives FDA Approval as First Biologic Treatment for Pediatric Ulcerative Colitis Approval Expands Access to REMICADE for Children Living with Ulcerative Colitis

被引：0
|
作者：
不详
机构：
来源：
PRACTICAL GASTROENTEROLOGY | 2011年 / 35卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：59 / 60
页数：2
相关论文
共 28 条
  • [1] Remicade - Infliximab for IV injection - Centocor - First biologic approved for ulcerative colitis
    不详
    FORMULARY, 2005, 40 (10) : 321 - 322
  • [2] Treatment of Choice for Acute Severe Steroid-Refractory Ulcerative Colitis Is Remicade
    Halfvarson, Jonas
    Jarnerot, Gunnar
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (01) : 143 - 145
  • [3] Extension of Approval for Stelara® (Ustekinumab) for the Treatment of Ulcerative colitis
    VISCERAL MEDICINE, 2019, 35 (06) : 399 - 399
  • [4] Remicade - Infliximab - Centocor - Chimeric monoclonal antibody approved for the treatment of ulcerative colitis and maintenance of clinical remission
    不详
    FORMULARY, 2006, 41 (12) : 621 - 622
  • [5] Patient perception and approval of fecal microbiota transplantation (FMT) as an alternative treatment option for ulcerative colitis
    Roggenbrod, Sebastian
    Schuler, Constantin
    Haller, Bernhard
    Sohn, Maximilian
    Storr, Martin
    Schepp, Wolfgang
    Gundling, Felix
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2019, 57 (03): : 296 - 303
  • [6] Remicade® Treatment Discontinuation and Associated Factors Among Patients With Crohn's Disease and Ulcerative Colitis in the US: 2012-2015
    Rosenthal, Ning
    Wu, David
    Arsever, Christiane
    Kartashov, Alex
    Baumer, Dorothy
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S1548 - S1548
  • [7] Model-Informed Approach Supporting Approval of Adalimumab (HUMIRA) in Pediatric Patients with Ulcerative Colitis from a Regulatory Perspective
    Ruo-Jing Li
    Lian Ma
    Hyewon Kim
    Insook Kim
    Lesley Hanes
    Tara Altepeter
    Jessica Lee
    Jiang Liu
    Hao Zhu
    Yaning Wang
    The AAPS Journal, 24
  • [8] Model-Informed Approach Supporting Approval of Adalimumab (HUMIRA) in Pediatric Patients with Ulcerative Colitis from a Regulatory Perspective
    Li, Ruo-Jing
    Ma, Lian
    Kim, Hyewon
    Kim, Insook
    Hanes, Lesley
    Altepeter, Tara
    Lee, Jessica
    Liu, Jiang
    Zhu, Hao
    Wang, Yaning
    AAPS JOURNAL, 2022, 24 (04)
  • [9] Durability of the First Biologic in Children and Adults With Ulcerative Colitis: A Nationwide Study from the epi-IIRN
    Atia, Ohad
    Friss, Chagit
    Focht, Gili
    Rimon, Ramit Magen
    Ledderman, Natan
    Greenfeld, Shira
    Ben-Tov, Amir
    Weisband, Yiska Loewenberg
    Matz, Eran
    Gorelik, Yuri
    Chowers, Yehuda
    Dotan, Iris
    Turner, Dan
    INFLAMMATORY BOWEL DISEASES, 2024, : 617 - 624
  • [10] Treatment and biologic maintenance-dosing patterns among pediatric patients with ulcerative colitis or Crohn's disease
    Hunter, Theresa
    Komocsar, Wendy J.
    Colletti, Richard B.
    Liu, Chunyan
    Benkov, Keith J.
    Dotson, Jennifer L.
    Steiner, Steven J.
    Zhang, Nanhua
    Crandall, Wallace
    Network, ImproveCareNow
    CURRENT MEDICAL RESEARCH AND OPINION, 2023, 39 (01) : 63 - 69
123